Skip to main content

Theophylline 24-Hour Extended Release Capsules and Tablets Shortage

Last Updated: April 5, 2024
Status: Current

Products Affected - Description
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 300 mg, bottle, 100 count, NDC 52244-0300-10
    • Theophylline extended release tablet, Rhodes, 400 mg, bottle, 100 count, NDC 42858-0701-01
    • Theophylline extended release tablet, Rhodes, 600 mg, bottle, 100 count, NDC 42858-0702-01
Reason for the Shortage
    • Endo did not provide a reason for the shortage.
    • Rhodes did not provide a reason for the shortage.
    • Glenmark has theophylline 24-hour extended-release tablets available. The company is reviewing orders.
Available Products
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 100 mg, bottle, 100 count, NDC 52244-0100-10
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 200 mg, bottle, 100 count, NDC 52244-0200-10
    • Theo-24 extended release capsule, Endo Pharmaceuticals, 400 mg, bottle, 100 count, NDC 52244-0400-10
    • Theophylline extended release tablet, Glenmark, 400 mg, bottle, 100 count, NDC 68462-0380-01
    • Theophylline extended release tablet, Glenmark, 600 mg, bottle, 100 count, NDC 68462-0356-01

Estimated Resupply Dates

    • Rhodes has all presentations on back order and the company cannot estimate a release date.
    • Endo has Theo-24 300 mg extended-release capsules on back order and the company cannot estimate a release date.

Updated

Updated April 5, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 22, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer